相关实验视频

Updated: Feb 28, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

Let-7a和miR-34a通过共同向FNDC3B,IGF2和SOX4相互作用,在肝细胞癌中发挥强大的抑制作用

Bangly Soliman^1,2, Ahmed Fawzy Ibrahim³, Ahmed Salem¹

¹Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo 1156, Egypt.

International journal of molecular sciences

|February 27, 2026

概括

let-7a和miR-34a微RNA通过降低SOX4等致癌点的调节来抑制肝细胞癌 (HCC). 它们的联合使用显示出对这种侵入性瘤的治疗潜力.

科学领域:

分子生物学分子生物学
在瘤学瘤学.
生物信息学是一种生物信息学.

背景情况:

let-7a和miR-34a是已知的肝细胞癌 (HCC) 抑制剂.
它们在HCC中的联合监管机制在很大程度上仍未被阐明.

研究的目的:

综合分析let-7a和miR-34a的in silico目标.
通过实验验证这些microRNAs对特定的致癌点 (FNDC3B,IGF2,SOX4) 的共同调节.
为了研究联合let-7a和miR-34a表达的抗HCC作用.

主要方法:

在使用miRWalk,Genetrail和miRnet.net的分析中.
在HepG2细胞中使用MTT测定,光显微镜,qPCR和免疫光学进行实验验证.
测量let-7a,miR-34a及其预测目标 (FNDC3B,IGF2,SOX4) 的量化.

主要成果:

生物信息学分析为let-7a和miR-34a发现了共同的预测肝癌性标.
三个目标 (FNDC3B,IGF2,SOX4) 被确定为共同监管和实验验证.
在HepG2细胞中let-7a和miR-34a的过度表达减少了瘤细胞的增殖,并降低了目标转录的调节.
miR-34a表现出优越的抑制效果,SOX4是最显著下调的目标.

结论:

let-7a和miR-34a通过对瘤点的共同调节,表现出相互关联的抗HCC效应.
结合使用let-7a和miR-34a,有可能改善肝细胞癌的治疗结果.
这些发现为针对HCC的能量代谢和免疫逃避提供了新的见解.

关键词:

联合监管机构的监管机构.新兴的HCC标志着新兴的HCC的特征.肝细胞癌是肝细胞癌.在分析中进行分析.在体外验证 in vitro 验证主要的HCC特征主要的HCC特征沉声器miRNAs的使用情况

更多相关视频

The Soft Agar Colony Formation Assay

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...